Yi-Hsien Shih

Dr. Yi-Hsien Shih

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2024 in Archives of Dermatological Research
Verified
Journal Article
Closed access
YLYu-Cheng Liu
Yu-Cheng Liu
SCShu-Han Chuang
Shu-Han Chuang
YCYu-Pin Chen
Yu-Pin Chen
YSYi-Hsien Shih
Yi-Hsien Shih

1 January 2016 in Journal of Cutaneous and Aesthetic Surgery
Verified
Journal Article
Open access
PDF file
CGChee Leok Goh
Chee Leok Goh
NNNopadon Noppakun
Nopadon Noppakun
GMGiuseppe Micali
Giuseppe Micali
NANoor Zalmy Azizan
Noor Zalmy Azizan
WBWaranya Boonchai
Waranya Boonchai
SWSuNi Wong
SuNi Wong
Conventional acne treatment presents several challenges such as intolerable side effects and antibiotic resistance. Dermocosmetic products may be used to reduce these unwanted effects. Dermocosmetics include skin cleansers, topical sebum-controllers, skin antimicrobial/anti-inflammatory agents, moisturizers, sunscreens, and camouflage products. Appropriate use of these products may help augment the benefit of acne treatment, minimize side effects, and reduce the need for topical antibiotics. In Asia, there is currently limited scientific data on the application and recommendations for dermocosmetic use in acne vulgaris (AV). This article reviews the evidence on dermocosmetics for AV and provides practice recommendations as discussed during the 4th Asia-Pacific Acne Leaders' Summit held in Bangkok, Thailand, on 7 and 8 February 2015. Through a premeeting survey, a series of plenary lectures, a stepwise program of discussion sessions, and Medline article review, the Expert Panel set forth relevant recommendations on the role of dermocosmetics as adjunct for treating AV in Asian patients.

29 July 2024 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
KTKuan-Yi Tu
Kuan-Yi Tu
CJChiau-Jing Jung
Chiau-Jing Jung
YSYi-Hsien Shih
Yi-Hsien Shih
ACAnne Lynn S. Chang
Anne Lynn S. Chang
Rosacea is a complex inflammatory condition characterized by papulopustular lesions and erythema on the central face for which there is no cure. The development of rosacea is influenced by both external triggers and genetics, but the common pathophysiology is overactivation of the immune system. Here, we review the current data on proinflammatory cytokines and dysregulation of the neurovascular system as targetable components of rosacea. Amelioration of cutaneous and gastrointestinal dysbiosis and other external factors impacts the immune state and has been observed to improve rosacea. While multiple treatments exist, many patients do not achieve their goals for rosacea control and highlights an unmet need for dermatologic care. Current interventions encompass topical/oral drugs, light devices, and avoidance of triggers management. Additional understanding of the underlying pathogenesis may help us develop novel targeted therapeutic strategies to improve rosacea.

1 April 2021 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
JHJamie L. Harden
Jamie L. Harden
YSYi-Hsien Shih
Yi-Hsien Shih
JXJin Xu
Jin Xu
RLRui Li
Rui Li
DRDivya Rajendran
Divya Rajendran
ACAnne Lynn S. Chang
Anne Lynn S. Chang

1 September 2015 in Molecular Carcinogenesis
Verified
Journal Article
Closed access
PDF file
WLWoan‐Ruoh Lee
Woan‐Ruoh Lee
SSShing‐Chuan Shen
Shing‐Chuan Shen
PWPei‐Ru Wu
Pei‐Ru Wu
CCChia‐Lun Chou
Chia‐Lun Chou
YSYi-Hsien Shih
Yi-Hsien Shih
MJMing‐Chung Jiang
Ming‐Chung Jiang

4 May 2020 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
AKA.M. Kumar
A.M. Kumar
ACA.S. Chiou
A.S. Chiou
YSYi-Hsien Shih
Yi-Hsien Shih
SLS. Li
S. Li
ACA.L.S. Chang
A.L.S. Chang